General Information of Drug (ID: DMVGJ84)

Drug Name
Ii-Key hybrid peptide vaccine
Indication
Disease Entry ICD 11 Status REF
Influenza A virus H1N1 infection 1E30 Phase 1 [1]
Cross-matching ID
TTD ID
D05KOP

References

1 Results from a phase I clinical study of the novel Ii-Key/HER-2/neu(776-790) hybrid peptide vaccine in patients with prostate cancer. Clin Cancer Res. 2010 Jul 1;16(13):3495-506.